CYLD Antikörper (AA 170-338)
-
- Target Alle CYLD Antikörper anzeigen
- CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
-
Bindungsspezifität
- AA 170-338
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CYLD Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- Verwendungszweck
- Polyclonal Antibody to Cylindromatosis (CYLD)
- Spezifität
- The antibody is a rabbit polyclonal antibody raised against CYLD. It has been selected for its ability to recognize CYLD in immunohistochemical staining and western blotting.
- Kreuzreaktivität
- Maus, Ratte
- Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
- Immunogen
- Recombinant Cylindromatosis (CYLD) corresdonding to Glu170~Gly338 (Accession # Q9NQC7)
- Isotyp
- IgG
-
anti-Cylindromatosis (Turban Tumor Syndrome) (CYLD) (AA 654-953) antibody
CYLD Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cylindromatosis (Turban Tumor Syndrome) (CYLD) (C-Term) antibodyCYLD Reaktivität: Human, Maus WB, ICC, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cylindromatosis (Turban Tumor Syndrome) (CYLD) (AA 204-358) antibodyCYLD Reaktivität: Human ELISA, FACS Wirt: Maus Monoclonal 5F7F4 unconjugated
anti-Cylindromatosis (Turban Tumor Syndrome) (CYLD) (AA 269-435), (C-Term) antibodyCYLD Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Cylindromatosis (Turban Tumor Syndrome) (CYLD) (pSer418) antibodyCYLD Reaktivität: Human, Maus WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cylindromatosis (Turban Tumor Syndrome) (CYLD) (AA 32-45) antibodyCYLD Reaktivität: Human, Maus, Hamster, Huhn, Rind (Kuh), Hund, Meerschweinchen, Pferd, Affe, Kaninchen WB, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Cylindromatosis (Turban Tumor Syndrome) (CYLD) (AA 305-582) antibodyCYLD Reaktivität: Human WB, FACS Wirt: Maus Monoclonal 1667CT857-3-6-1 unconjugated
anti-Cylindromatosis (Turban Tumor Syndrome) (CYLD) (AA 854-953) antibodyCYLD Reaktivität: Human ELISA, IF Wirt: Maus Monoclonal 3A9 unconjugated
anti-Cylindromatosis (Turban Tumor Syndrome) (CYLD) (AA 854-953) antibodyCYLD Reaktivität: Human ELISA, IF Wirt: Maus Monoclonal 2C3 unconjugated
anti-Cylindromatosis (Turban Tumor Syndrome) (CYLD) (C-Term) antibodyCYLD Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Western blotting: 0.5-2 μg/mL
1:470-1900 Immunohistochemistry: 5-20 μg/mL
1:47-190 Immunocytochemistry: 5-20 μg/mL
1:47-190 Optimal working dilutions must be determined by end user.
- Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 24 months
-
- Target
- CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
- Andere Bezeichnung
- Cylindromatosis (CYLD Produkte)
- Hintergrund
- CDMT, CYLD1, CYLDI, EAC, USPL2, Turban Tumor Syndrome, Ubiquitin Carboxyl-Terminal Hydrolase CYLD, Ubiquitin Specific Peptidase Like 2, Deubiquitinating enzyme CYLD
- Pathways
- Apoptose, Activation of Innate immune Response
-
